Results 261 to 270 of about 279,323 (388)
Chronic peptic ulceration and nonsteroidal anti-inflammatory drugs: More to be said about NSAIDs?
Nicholas J. Talley
openalex +1 more source
Objective To describe Australian practices and attitudes regarding equine analgesia. Study Design Cross‐sectional anonymous, voluntary survey of Australian veterinarians treating equine patients. Methods Australian veterinarians in equine or mixed practices completed a six‐section, 60‐question survey between November 2019 to August 2020.
A Whitelock +8 more
wiley +1 more source
Self-reporting of adverse drug reactions of nonsteroidal anti-inflammatory drugs in community pharmacies. [PDF]
Olson PS +7 more
europepmc +1 more source
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.
T. Grosser, E. Ricciotti, G. FitzGerald
semanticscholar +1 more source
Abstract Chronic pain, marked by nociceptive sensitization and maladaptive neuroplasticity, affects 30% of the global population with escalating socioeconomic burdens. Epidemiological data show a 2‐3‐fold increase in neuropsychiatric co‐morbidities among individuals with chronic pain, where epigenetic dysregulation serves as a key mechanism linking ...
Kai Zhang +18 more
wiley +1 more source
Intravenously Administered Nonsteroidal Anti-Inflammatory Drugs in Clinical Practice: A Narrative Review. [PDF]
Maurice-Szamburski A +4 more
europepmc +1 more source
Liver injury from nonsteroidal anti‐inflammatory drugs in the United States
Paul A. Schmeltzer +6 more
semanticscholar +1 more source
Opioids in breast cancer: Between analgesia and modulation of tumour progression
Preclinical investigations consistently demonstrate that activation of μ‐opioid receptors and δ‐opioid receptors promote proliferation, migration, angiogenesis, epithelial‐mesenchymal transition, acquisition of cancer stem cell phenotypes, and chemoresistance.
Marianna Ciwun +2 more
wiley +1 more source
Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years.
J. Wallace
semanticscholar +1 more source
Background The activity of CYP2C9, an important drug metabolism enzyme, is subject to the impact of genetic polymorphism. The single nucleotide polymorphism *3 is significantly associated with the increased exposure of CYP2C9 substrates. In addition, metabolic enzyme inhibitors such as fluconazole may also increase the drug exposure of CYP2C9 ...
Shen Cheng +5 more
wiley +1 more source

